• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 5: coronary artery disease.

作者信息

Thompson P D, Klocke F J, Levine B D, Van Camp S P

出版信息

Med Sci Sports Exerc. 1994 Oct;26(10 Suppl):S271-5.

PMID:7934751
Abstract
摘要

相似文献

1
26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 5: coronary artery disease.
Med Sci Sports Exerc. 1994 Oct;26(10 Suppl):S271-5.
2
26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 5: coronary artery disease.
J Am Coll Cardiol. 1994 Oct;24(4):888-92. doi: 10.1016/0735-1097(94)90846-x.
3
26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 1: congenital heart disease.
Med Sci Sports Exerc. 1994 Oct;26(10 Suppl):S246-53.
4
26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 4: systemic hypertension.第26届贝塞斯达会议：关于确定心血管异常运动员参赛资格的建议。特别工作组4：系统性高血压。
Med Sci Sports Exerc. 1994 Oct;26(10 Suppl):S268-70.
5
26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 6: arrhythmias.第26届贝塞斯达会议：关于确定心血管异常运动员参赛资格的建议。第6工作组：心律失常
Med Sci Sports Exerc. 1994 Oct;26(10 Suppl):S276-83.
6
26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 3: hypertrophic cardiomyopathy, myocarditis and other myopericardial diseases and mitral valve prolapse.第26届贝塞斯达会议：关于确定心血管异常运动员参赛资格的建议。第3工作组：肥厚型心肌病、心肌炎及其他心肌心包疾病和二尖瓣脱垂。
Med Sci Sports Exerc. 1994 Oct;26(10 Suppl):S261-7.
7
26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 2: acquired valvular heart disease.第26届贝塞斯达会议：关于确定心血管异常运动员参赛资格的建议。特别工作组2：后天性心脏瓣膜病。
Med Sci Sports Exerc. 1994 Oct;26(10 Suppl):S254-60.
8
Cardiovascular disease in athletes.运动员的心血管疾病
Clin Sports Med. 2004 Jul;23(3):455-71, x. doi: 10.1016/j.csm.2004.02.002.
9
Legal considerations that affect medical eligibility for competitive athletes with cardiovascular abnormalities and acceptance of Bethesda Conference recommendations.
Med Sci Sports Exerc. 1994 Oct;26(10 Suppl):S238-41.
10
26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 4: systemic hypertension.第26届贝塞斯达会议：关于确定心血管异常运动员参赛资格的建议。第4工作组：系统性高血压。
J Am Coll Cardiol. 1994 Oct;24(4):885-8. doi: 10.1016/0735-1097(94)90845-1.

引用本文的文献

1
Platelet hyperactivity during exercise leading to iterative coronary stent thrombosis: clinical implications.运动期间血小板活性增高导致冠状动脉支架内血栓形成的反复发作：临床意义。
J Thromb Thrombolysis. 2010 Jul;30(1):105-8. doi: 10.1007/s11239-009-0394-3.